###begin article-title 0
Analysis of Germline GLI1 Variation Implicates Hedgehog Signalling in the Regulation of Intestinal Inflammatory Pathways
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 420 424 420 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 468 476 <span type="species:ncbi:9606">patients</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
Ulcerative colitis (UC) and Crohn's disease (CD) are polygenic chronic inflammatory bowel diseases (IBD) of high prevalence that are associated with considerable morbidity. The hedgehog (HH) signalling pathway, which includes the transcription factor glioma-associated oncogene homolog 1 (GLI1), plays vital roles in gastrointestinal tract development, homeostasis, and malignancy. We identified a germline variation in GLI1 (within the IBD2 linkage region, 12q13) in patients with IBD. Since this IBD-associated variant encodes a GLI1 protein with reduced function and our expression studies demonstrated down-regulation of the HH response in IBD, we tested whether mice with reduced Gli1 activity demonstrate increased susceptibility to chemically induced colitis.
###end p 2
###begin title 3
Methods and Findings
###end title 3
###begin p 4
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 268 272 268 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 341 342 341 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 406 410 404 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 511 512 509 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 524 528 522 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 953 959 951 957 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 949 959 947 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 1151 1157 1149 1155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 1147 1157 1145 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 123 131 <span type="species:ncbi:9606">patients</span>
###xml 922 930 <span type="species:ncbi:9606">patients</span>
###xml 960 964 <span type="species:ncbi:10090">mice</span>
###xml 1158 1162 <span type="species:ncbi:10090">mice</span>
Using a gene-wide haplotype-tagging approach, germline GLI1 variation was examined in three independent populations of IBD patients and healthy controls from Northern Europe (Scotland, England, and Sweden) totalling over 5,000 individuals. On log-likelihood analysis, GLI1 was associated with IBD, predominantly UC, in Scotland and England (p < 0.0001). A nonsynonymous SNP (rs2228226C-->G), in exon 12 of GLI1 (Q1100E) was strongly implicated, with pooled odds ratio of 1.194 (confidence interval = 1.09-1.31, p = 0.0002). GLI1 variants were tested in vitro for transcriptional activity in luciferase assays. Q1100E falls within a conserved motif near the C terminus of GLI1; the variant GLI protein exhibited reduced transactivation function in vitro. In complementary expression studies, we noted the colonic HH response, including GLI1, patched (PTCH), and hedgehog-interacting protein (HHIP), to be down-regulated in patients with UC. Finally, Gli1+/lacZ mice were tested for susceptibility to dextran sodium sulphate (DSS)-induced colitis. Clinical response, histology, and expression of inflammatory cytokines and chemokines were recorded. Gli1+/lacZ mice rapidly developed severe intestinal inflammation, with considerable morbidity and mortality compared with wild type. Local myeloid cells were shown to be direct targets of HH signals and cytokine expression studies revealed robust up-regulation of IL-12, IL-17, and IL-23 in this model.
###end p 4
###begin title 5
Conclusions
###end title 5
###begin p 6
HH signalling through GLI1 is required for appropriate modulation of the intestinal response to acute inflammatory challenge. Reduced GLI1 function predisposes to a heightened myeloid response to inflammatory stimuli, potentially leading to IBD.
###end p 6
###begin p 7
###xml 190 195 <span type="species:ncbi:10090">mouse</span>
Charlie Lees and colleagues identify a reduced-function variant of the hedgehog signaling pathway protein GLI1 that associates with inflammatory bowel disease, and investigate its role in a mouse model of colitis.
###end p 7
###begin title 8
Editors' Summary
###end title 8
###begin title 9
Background.
###end title 9
###begin p 10
Inflammatory bowel diseases (IBDs) are common disorders in which parts of the digestive tract become repeatedly or continuously inflamed. The immune system normally protects the body from entities it identifies as foreign, but in IBD it mistakenly recognizes gut tissue, and immune system cells accumulate in the lining of the bowel, which causes inflammation. There are two main types of IBD-Crohn's disease (CD), which mainly affects the small bowel, and ulcerative colitis (UC), which affects only the large bowel (colon). Both types tend to run in families and usually develop between the ages of 15 and 35 years. Symptoms-including diarrhea, abdominal cramps, and unexplained weight loss-can be mild or severe and the disease can develop slowly or suddenly. There is no cure for IBD except surgical removal of the affected part of the digestive tract. However, drugs that modulate the immune system (for example, corticosteroids) or that specifically inhibit "proinflammatory cytokines" (proteins made by the immune system that stimulate inflammation) are often helpful in reducing symptoms.
###end p 10
###begin title 11
Why Was This Study Done?
###end title 11
###begin p 12
###xml 698 702 698 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 773 777 773 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 44 50 <span type="species:ncbi:9606">people</span>
###xml 474 480 <span type="species:ncbi:9606">people</span>
Why the immune system becomes unbalanced in people with IBD is not clear but it is known that IBD is "polygenic," that is, a disease caused by the combined actions of two or more inherited gene variants. Although UC and CD are clinically different diseases, they share several "susceptibility loci" (regions of the genome that harbor disease-associated gene variants), including the IBD2 locus. The identification of the actual gene within the IBD2 locus that is altered in people who are susceptible to IBD might provide new insights into what causes the immune imbalance in IBD and into how to treat the disease. In this study, the researchers test the hypothesis that a variant of a gene called GLI1, which lies in the IBD2 locus, is associated with IBD susceptibility. GLI1 encodes a transcription factor (a protein that regulates the production of proteins) that is a central component in the signaling pathway named for a protein called "hedgehog." This pathway is involved in the development of many organs, including the digestive tract.
###end p 12
###begin title 13
What Did the Researchers Do and Find?
###end title 13
###begin p 14
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLl1</italic>
###xml 214 218 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 770 776 770 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 766 776 766 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 1308 1314 1308 1314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 1304 1314 1304 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 107 115 <span type="species:ncbi:9606">patients</span>
###xml 140 146 <span type="species:ncbi:9606">people</span>
###xml 692 700 <span type="species:ncbi:9606">patients</span>
###xml 777 781 <span type="species:ncbi:10090">mice</span>
###xml 906 910 <span type="species:ncbi:10090">mice</span>
###xml 1315 1319 <span type="species:ncbi:10090">mice</span>
###xml 1342 1346 <span type="species:ncbi:10090">mice</span>
The researchers used a technique called gene-wide haplotype tagging to look for inherited GLl1 variants in patients with IBD and in healthy people living in Scotland, England, and Sweden. A specific variant of the GLI1 gene, resulting in alteration of a single amino acid component of the GLI1 protein, was associated with IBD (particularly with UC) in both Scotland and England; the same variant was weakly associated with IBD in the Swedish population. The variant GLI1 protein was only half as active as the normal protein in a laboratory assay, and, consistent with this result, the expression of several components of the hedgehog signaling pathway was lower in colon samples taken from patients with UC than in samples taken from healthy individuals. Finally, Gli1+/lacZ mice (which express half the normal amount of Gli1 protein) developed severe intestinal inflammation more rapidly than wild-type mice when they were treated with dextran sodium sulfate (DSS), a chemical that induces acute (sudden) colitis. Cellular analysis revealed that myeloid cells (cells that sense and modify the inflammatory response) are direct targets of the hedgehog signaling pathway. Furthermore, the expression of several pro-inflammatory cytokines (in particular, one called IL-23) increased more markedly in the Gli1+/lacZ mice than in the wild-type mice after DSS treatment.
###end p 14
###begin title 15
What Do These Findings Mean?
###end title 15
###begin p 16
###xml 269 273 269 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 406 410 406 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 236 241 <span type="species:ncbi:9606">human</span>
###xml 702 707 <span type="species:ncbi:9606">human</span>
These findings suggest that the normal response of the mammalian gut to challenge with inflammatory substances involves hedgehog signaling through GLI1 and that reduced GLI1 function might be one trigger for IBD. More specifically, the human genetic studies identify a GLI1 variant that is associated with IBD (at least in certain north European populations), the laboratory experiments indicate that this GLI1 variant encodes a protein with reduced activity, and the animal studies show that a similar reduction in Gli1 activity is sufficient to heighten intestinal inflammatory responses. Although this last result needs to be confirmed in animal models of chronic colitis that more closely resemble human IBD, these findings suggest that drugs that modulate hedgehog signaling might be useful in the treatment of IBD.
###end p 16
###begin title 17
Additional Information.
###end title 17
###begin p 18
Please access these Web sites via the online version of this summary at .
###end p 18
###begin p 19
The MedlinePlus Encyclopedia has pages on  and on  (in English and Spanish)
###end p 19
###begin p 20
MedlinePlus provides links to other information  and  (in English and Spanish)
###end p 20
###begin p 21
The US National Institute of Diabetes and Digestive and Kidney Diseases provides information on  and
###end p 21
###begin p 22
The UK National Health Service Direct Encyclopedia also provides information on  and on
###end p 22
###begin p 23
Wikipedia has a page on  (note: Wikipedia is a free online encyclopedia that anyone can edit; available in several languages)
###end p 23
###begin title 24
Introduction
###end title 24
###begin p 25
###xml 246 247 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b001">1</xref>
###xml 474 475 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b002">2</xref>
###xml 671 677 671 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-23R</italic>
###xml 679 685 679 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-12B</italic>
###xml 691 697 691 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NKX2.3</italic>
###xml 722 726 722 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 728 735 728 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATG16L1</italic>
###xml 741 745 741 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRGM</italic>
###xml 773 777 773 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ECM1</italic>
###xml 807 808 807 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b003">3</xref>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b010">10</xref>
###xml 879 880 879 880 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 988 990 988 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b011">11</xref>
###xml 1168 1170 1168 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b012">12</xref>
###xml 1171 1173 1171 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b013">13</xref>
###xml 49 52 <span type="species:ncbi:9606">Man</span>
###xml 862 865 <span type="species:ncbi:9606">Man</span>
###xml 1017 1025 <span type="species:ncbi:9606">patients</span>
Ulcerative colitis (UC; Mendelian Inheritance in Man [MIM] 191390) and Crohn's disease (CD; MIM 266600) are chronic, relapsing, inflammatory bowel diseases (IBD) of high prevalence (200-400 cases per 100,000 in Northern Europe and North America [1]) and are associated with considerable morbidity. Precise aetio-pathogenetic mechanisms are not understood but several lines of evidence implicate the central importance of a dysregulated host response to intestinal bacteria [2]. Epidemiological data, detailed molecular studies, and recent genome-wide association studies strongly suggest that UC and CD are related polygenic diseases that share some susceptibility loci (IL-23R, IL-12B, and NKX2.3), but differ at others: NOD2, ATG16L1, and IRGM are specific CD genes; the ECM1 locus is associated with UC [3-10]. The IBD2 locus (Online Mendelian Inheritance in Man [OMIM] 601458) on Chromosome 12q13 was first identified in a UK genome-wide linkage scan (peak LOD score 5.47 at D12S83) [11] involving both UC and CD patients. Later studies showed that IBD2 contributes significantly to UC, notably extensive disease, but perhaps in a lesser way to CD susceptibility [12,13].
###end p 25
###begin p 26
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b014">14</xref>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b014">14</xref>
###xml 712 721 712 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050239-sg001">Figure S1</xref>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b014">14</xref>
###xml 957 959 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b015">15</xref>
###xml 969 971 969 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b016">16</xref>
###xml 972 974 972 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b017">17</xref>
###xml 987 989 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b018">18</xref>
###xml 990 992 990 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b019">19</xref>
###xml 1122 1124 1122 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b020">20</xref>
###xml 1163 1165 1163 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b021">21</xref>
###xml 1166 1168 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b022">22</xref>
###xml 1214 1216 1214 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b023">23</xref>
###xml 1316 1318 1312 1314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b024">24</xref>
###xml 1482 1484 1478 1480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b025">25</xref>
###xml 1757 1759 1753 1755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b026">26</xref>
###xml 1133 1138 <span type="species:ncbi:9606">human</span>
A strong candidate gene that maps to the IBD2 locus is GLI1, one of three related GLI transcription factors that transduce secreted hedgehog (HH) signals. HH signalling is key in gut development, homeostasis, and malignancy, but has not been carefully studied in IBD [14]. In developing intestine, Sonic (SHH) and Indian Hedgehog (IHH) provide a paracrine signal from epithelium to the mesenchymally expressed receptor patched (PTCH) [14]. The binding of HH to PTCH releases the membrane protein smoothened (SMO) from inhibition and allows HH signal transduction through the zinc finger transcription factors glioma-associated oncogene homolog 1 (GLI1), GLI2, and GLI3 to direct tissue patterning and cell fate (Figure S1) (see [14] and citations therein). Chronic injury, inflammation, and repair are critical aspects of IBD, and thus it is pertinent that the HH pathway is centrally involved in these processes in several other tissues, including muscle [15], liver [16,17], and lung [18,19]. Indeed, HH signalling may play a central role in the inflammatory response since SHH is critical for T lymphocyte development [20], adult human CD4+ T cell activation [21,22], and myeloid cell maturation in the spleen [23]. Furthermore, SHH has recently been suggested to be a direct transcriptional target of NF-kappaB [24]. Dysregulation of components of the HH pathway has also been noted in inflammatory diseases of the gut, including Barrett oesophagus, chronic gastritis, and IBD [25]. Using microarray gene expression analyses of colonoscopic biopsies, we recently demonstrated that GLI1 expression is greater in the distal compared with the proximal colon, and is down-regulated in the intestinal mucosa in inflamed UC compared with noninflamed samples [26].
###end p 26
###begin p 27
###xml 304 308 304 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 629 635 629 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 625 635 625 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 157 162 <span type="species:ncbi:9606">human</span>
###xml 175 181 <span type="species:ncbi:10090">murine</span>
###xml 249 254 <span type="species:ncbi:9606">human</span>
###xml 430 436 <span type="species:ncbi:9606">humans</span>
###xml 636 640 <span type="species:ncbi:10090">mice</span>
Taken together, these studies suggested a possible association between GLI1 and IBD susceptibility, and we set out to directly test this possibility in both human disease and murine model systems. Our main initial objectives were to ascertain, from human genetic association study data, whether germline GLI1 variation was associated with IBD, and to describe the expression of HH signalling components in colonic inflammation in humans. These results led us to hypothesize that a reduced dosage of functional GLI1 protein might play an important role in colonic inflammation. To test this hypothesis directly, we challenged Gli1+/lacZ mice and their wild-type (WT) littermates with dextran sodium sulphate (DSS) to induce acute intestinal inflammation, and monitored clinical and histological parameters, cytokine profiles, and cellular targets of HH signalling in vivo.
###end p 27
###begin title 28
Methods
###end title 28
###begin p 29
###xml 277 278 277 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
###xml 277 278 277 278 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>.</italic></bold>
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Written, informed consent was obtained from all patients and controls. The study protocol was approved by the Lothian Research and Ethics Committee (LREC-2000/4/192 and 2004/S1103/22); Cambridge (LREC-01/418; MREC-03/5/012); and Regional Ethics Committee, Karolinska Institutet.
###end p 29
###begin title 30
###xml 0 12 <span type="species:ncbi:9606">Participants</span>
Participants and Samples
###end title 30
###begin title 31
Individuals for genotyping.
###end title 31
###begin p 32
###xml 148 155 148 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0050239-t001">Table 1</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b027">27</xref>
###xml 289 297 <span type="species:ncbi:9606">patients</span>
In Scotland the population consisted of 817 IBD cases (474 UC; 335 CD; eight colonic IBD type unclassified [IBDU]) and 1,374 healthy controls (HC) (Table 1). Diagnosis was made by clinical, radiological, and histopathological means, adhering to the criteria of Lennard-Jones [27]. All IBD patients attended the clinic at the Western General Hospital (Edinburgh, Scotland), a tertiary referral centre for IBD in southeast Scotland. The population was 98.5% white, non-Jewish. The median age at diagnosis was 31.0 y (IQR 23.3-46.0). Controls were recruited from across Scotland; median age was 50.0 (IQR 43.0-55.0), ethnicity >99% white, non-Jewish, and 48.7% male sex.
###end p 32
###begin p 33
Detailed Demographics and Phenotypic Data on Scottish, Cambridge, and Swedish IBD Population
###end p 33
###begin p 34
###xml 52 60 <span type="species:ncbi:9606">patients</span>
In Cambridge, England 1,748 unrelated Caucasian IBD patients (Lennard-Jones criteria) of northern European origin attending IBD clinics in East Anglia, UK were recruited comprising 928 UC, 737 CD, and 83 with IBDU. The population was >99% white, non-Jewish. The 589 ethnically and geographically matched HCs were previously recruited in East Anglia for the European Prospective Investigation of Nutrition and Cancer (EPIC). Median age of controls was 60 y.
###end p 34
###begin p 35
###xml 207 208 207 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 259 260 259 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 28 36 <span type="species:ncbi:9606">patients</span>
###xml 249 257 <span type="species:ncbi:9606">patients</span>
In Sweden 288 UC and 205 CD patients (Lennard-Jones criteria) were recruited from various hospitals in Stockholm County. 281 Swedish HC were healthy volunteers from the Karolinska University Hospital staff (n = 170) and orthopaedic day-case surgery patients (n = 111) with no previous medical conditions. Cases and controls were >99% white, non-Jewish.
###end p 35
###begin title 36
###xml 11 12 11 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
Phenotyping.
###end title 36
###begin p 37
###xml 137 144 137 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0050239-t001">Table 1</xref>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b028">28</xref>
###xml 34 41 <span type="species:ncbi:9606">patient</span>
Phenotypic data were collected by patient questionnaire, interview, and case note review, and classified according to Montreal criteria (Table 1) [28].
###end p 37
###begin title 38
Genotyping
###end title 38
###begin title 39
Scotland and Sweden.
###end title 39
###begin p 40
###xml 682 683 682 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Genomic DNA was extracted from blood samples using a modified salting-out technique as previously described, and Nucleon kits. Genotypes were derived using the Taqman system for allelic discrimination; the assays were available from Applied Biosystems as Taqman SNP Genotyping Assays (7900HT sequence detection system; Applied Biosystems), except for SNPs rs10783819, rs3809114, rs507562, rs542278, rs730560, rs1669296, and rs775322, which were genotyped on the Illumina platform. The accuracy of each Taqman assay was checked by repeat analysis in 5% of cases, with 100% concordance. Genotype distributions in all populations were consistent with Hardy-Weinberg equilibrium (HWE) (p > 0.01) for all SNPs. For the four tagging SNPs (tSNPs) that could not be derived by Taqman, genotypes were obtained by direct sequencing.
###end p 40
###begin title 41
Cambridge.
###end title 41
###begin p 42
###xml 569 570 569 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
DNA was extracted using Nucleon kits. Genotyping of CD cases and controls was performed using the Taqman biallelic discrimination system using an ABI 7900HT analyser (Applied Biosystems). Genotyping of UC cases was performed using a 1,536-SNP Golden Gate bead array (Illumina). Concordance between platforms was assessed by genotyping 92 UC cases for SNPs rs2228224 and rs2228226 with concordance rates of 100% and 97.9% respectively and no evidence of systematic bias between platforms. Genotype distributions in case and control populations were consistent with HWE (p > 0.01) for all SNPs.
###end p 42
###begin title 43
Gene Expression by Microarray and Quantitative Reverse-Transcription PCR
###end title 43
###begin p 44
###xml 14 22 <span type="species:ncbi:9606">patients</span>
###xml 70 78 <span type="species:ncbi:9606">patients</span>
###xml 119 127 <span type="species:ncbi:9606">patients</span>
###xml 411 419 <span type="species:ncbi:9606">patients</span>
The cohort of patients used in the microarray studies consisted of 67 patients with UC, 53 with CD, and 31 HCs. For UC patients, eight were recruited at diagnosis (treatment naive), 18 had active disease, and 41 quiescent disease; ten were on systemic corticosteroid therapy, 11 on immunosuppressants (azathioprine, mercaptopurine, or methotrexate), and 40 on 5-amino salicylic acid (5-ASA) therapy. Four of 53 patients with CD were on corticosteroids, 13 of 53 on immunosuppressants, and 21 of 53 on a 5-ASA. Eight of 31 HC had non-IBD inflammation: two scattered lymphoid aggregates with history of gastroenteritis, two microscopic colitis, one pseudomembranous colitis, one diverticulitis, one amoebiasis, and one eosinophilic infiltrate.
###end p 44
###begin p 45
###xml 436 437 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
###xml 623 625 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b026">26</xref>
The assessment of RNA quality and integrity was performed for the microarray experiments as follows: the amplified cRNA was purified using the RNeasy Mini Kit protocol (Qiagen) and 1 mul of amplified cRNA was quantified using the NanoDrop ND-1000 Spectrophotometer. The distribution of log intensities for each sample was plotted and outlier samples (i.e., greater than two standard deviations from the mean) were excluded from analysis. For additional demographics, phenotyping, and full methodology pertaining to the generation of the microarray dataset and quantitative reverse-transcription PCR (QPCR) see Noble et al [26].
###end p 45
###begin title 46
Induction of DSS-Induced Colitis and Histological Analysis
###end title 46
###begin p 47
###xml 29 35 29 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 25 35 25 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 269 275 269 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 265 275 265 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 308 314 308 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 304 314 304 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 390 396 390 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 386 396 386 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 489 490 489 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 528 534 528 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 524 534 524 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 1396 1398 1395 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b029">29</xref>
Groups of two to four WT Gli1+/lacZ or WT littermate controls in mixed cages (bred at least three generations onto a C57BL/6 background) were administered 3% DSS in drinking water for 4-6 d. The amount of DSS consumed was not significantly different between WT and Gli1+/lacZ animals (unpublished data). Gli1+/lacZ animals tended to weigh more than their WT littermates (mean, 28 g for Gli1+/lacZ animals and 24 g for WT animals). Therefore, DSS-treated weight matched WT C57Bl/6 animals (n = 4) were also tested along with Gli1+/lacZ animals and WT littermates. No differences were evident between WT littermates and weight matched C57Bl/6. All animals were monitored daily for diarrhoea, bloody stool, and weight loss. Clinical scoring was as follows: 0, no symptoms; 1, diarrhoea; 2, bloody stool; 4, severe rectal bleeding and morbidity to the point of immobility/death. For histology, a segment of large intestine tissue of equal length and location for all animals was fixed overnight in 4% paraformaldehyde, dehydrated, infiltrated with paraffin, and sectioned at 5 mum. The remaining colonic tissue was taken for RNA analysis or frozen sectioning and Gli1-LacZ expression analysis. Slides were stained with haematoxylin/eosin and scored histologically by a gastrointestinal pathologist (H.D.A.) blinded to the source of the tissue. Colitis scores were calculated using published methods [29].
###end p 47
###begin title 48
Gli1-LacZ Immunohistochemistry
###end title 48
###begin p 49
Colonic tissue was dissected out in cold PBS and fixed for 30 min in 4% PFA at 4 degreesC. After a brief rinsing in PBS, the tissue was incubated in 30% sucrose/PBS at 4 degreesC overnight and then embedded in OCT and frozen on dry ice.
###end p 49
###begin p 50
###xml 138 142 <span type="species:ncbi:9925">goat</span>
###xml 282 285 <span type="species:ncbi:10116">rat</span>
###xml 314 318 <span type="species:ncbi:9925">goat</span>
###xml 391 397 <span type="species:ncbi:9986">rabbit</span>
Immunohistochemistry was performed on 8- to 10-mum frozen sections. Sections were dried, rinsed in PBS, and blocked for 1 h in 10% normal goat serum, 0.1% BSA, and 0.3% Triton-X in TBS (50 mM Tris-HCl [pH 7.4], 150 mM NaCl). Antibodies used were: hamster anti-CD3 (Serotec, 1:500), rat anti-CD19 (Serotec, 1:500), goat anti-CD11b (Abcam 1:500), FITC-conjugated anti-CD11c (Abcam 1:250), and rabbit anti-beta-galactosidase (a gift of J. Douglas Engel, Department of Cell and Developmental Biology, University of Michigan, 1:2,000). All antibody staining was performed over night at 4 degreesC, followed by incubation with fluorophore-labeled Alexafluor secondary antibodies from Molecular Probes, 1:1,000 for 1 h. Nuclei were counterstained with DAPI, and slides were mounted in Prolong Gold Antifade Reagant (Invitrogen). Images were taken using an Olympus BX51 at 200x for immunofluorescence and an Olympus FV500 confocal microscope at 1,000x for 0.30-mum optical sectioning.
###end p 50
###begin title 51
GLI1 Protein Mutagenesis, Luciferase Assay, and Immunofluorescence
###end title 51
###begin p 52
###xml 946 947 940 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1154 1159 <span type="species:ncbi:10090">mouse</span>
###xml 1187 1192 <span type="species:ncbi:10090">mouse</span>
GLI1 E1100 was amplified from Image Clone number 3531657, and cloned into pCMV-Tag2b, adding an N-terminal FLAG motif. GLI1 Q1100 was obtained by inducing a point mutation using the QuikChange II Site-Directed Mutagenesis Kit (Stratagene) following the manufacturer's protocol. Plasmids encoding 8xGli-Luciferase, m8x Gli-Luciferase (mutated Gli sites), and Gli2DeltaN were gifts of Andrzej Dlugosz (University of Michigan). 293T cells were plated in 12-well plates, transfected with 0.7 mug/well transcription factor, 0.4 mug/well reporter plasmid, and 2 ng/well pRL-TK Renilla (Promega), and analyzed for luciferase expression 36 h after transfection using the Dual-Luciferase Reporter kit (Promega) following the manufacturer's protocol. Firefly luciferase expression was normalized by well to Renilla, and fold changes were calculated by comparing to 8xGli-Luciferase transfected alone. Statistical analysis was performed using the Student's t-test. For immunofluorescence, 293T cells grown on collagen-coated coverslips were transfected with 1.5 mug/well of transcription factor and analyzed after 36 h. FLAG-tagged GLI1 isoforms were detected with mouse-anti-FLAG (Sigma) and anti-mouse AlexaFlour488 (Molecular Probes) both at 1:1,000.
###end p 52
###begin title 53
Cytokine Expression QPCR
###end title 53
###begin p 54
###xml 415 416 415 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Colonic tissue was carefully cleaned of all fatty tissue and whole colonic mRNA was collected using Trizol, followed by RNA clean-up with DNase digestion using the RNeasy Mini Kit (Qiagen). cDNA was synthesized using the iScript cDNA synthesis kit (Biorad), and SybrGreen QPCR was performed on a Biorad iCycler. Expression levels were normalized to GAPDH, and statistical analysis was performed using the Student's t-test.
###end p 54
###begin title 55
Statistical Analysis
###end title 55
###begin p 56
###xml 314 315 312 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 334 335 332 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 366 367 364 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 430 431 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 561 562 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 562 563 560 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 662 663 658 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 723 724 719 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1046 1053 1042 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050239-sd001">Text S1</xref>
###xml 1109 1110 1105 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
Haplotype frequencies of the tSNPs were inferred using the expectation-maximization algorithm and these used to test whether haplotype frequencies were different in cases and controls as implemented in the EH and PM programmes. The test statistic 2 x (lnLcase] + ln[Lcontrol] - ln[Lcase/Lcontrol]), which has a chi2 distribution with n - 1 degrees of freedom (where n = number of possible haplotypes) was calculated and empirical p-values obtained by permuting the data 10,000 times. Haplotypes were examined and linkage disequilibrium between individual SNPs (r2) calculated using the Haploview programme v3.2 (). Individual SNP analysis was performed using chi2 or Fisher's exact test, where appropriate, with two-tailed p-values given and odds ratios (OR) presented with 95% confidence intervals (CIs). The meta-analysis of SNP rs2228226 was performed using the Mantel-Haenszel method using a fixed effects model (R-software package). Details for calculation of false positive report probability (FPRP) are provided in Supporting Information (Text S1). Expression profiles were analysed using Mann-Whitney U-test and Kruskal-Wallis test, assuming a nonparametric distribution of all datasets (GraphPad Prism 4, GraphPad Software Inc.).
###end p 56
###begin title 57
Results
###end title 57
###begin title 58
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
Gene-Wide Variation in GLI1 Is Associated with IBD and Attributable to a Nonsynonymous SNP (rs2228226) in the Scottish Population
###end title 58
###begin p 59
###xml 25 26 25 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 26 27 26 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 138 142 136 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 311 318 309 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0050239-t001">Table 1</xref>
###xml 357 359 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b030">30</xref>
###xml 388 392 386 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 501 502 499 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 521 522 519 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 589 590 587 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 720 728 718 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050239-st001">Table S1</xref>
###xml 781 785 779 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 975 979 973 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 1050 1055 1048 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INHBE</italic>
###xml 1060 1067 1058 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARHGAP9</italic>
###xml 1070 1079 1068 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050239-sg002">Figure S2</xref>
###xml 932 940 <span type="species:ncbi:9606">patients</span>
Four multi-marker tSNPs (r2 >/= 0.8) were identified (rs3817474, rs2228225, rs2228224, and rs2228226) to describe haplotypic variation of GLI1, detecting haplotypes of a frequency >1%. We genotyped these four tSNPs in a Scottish IBD population consisting of 474 UC and 335 CD cases, and 1,364 well-matched HCs (Table 1). We then used a model-free analysis [30] to test the association of GLI1 and IBD susceptibility. In the Scottish population, we demonstrate a highly significant association in IBD (p < 0.0001) and UC (p < 0.0001), and an association with CD of borderline significance (p = 0.03). On analysis of individual estimated haplotype frequencies in Haploview, three common haplotypes were described (A to C; Table S1). We confirmed that this effect was confined to the GLI1 gene by genotyping an additional seven haplotype-tagging SNPs, chosen from Phase II HapMap data, to tag neighbouring blocks, in 166 CD and 170 UC patients. This confirmed the presence of a GLI1 spanning haplotype block that did not extend into neighbouring genes (INHBE and ARHGAP9) (Figure S2).
###end p 59
###begin p 60
###xml 127 131 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 153 154 151 152 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 235 236 233 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 284 285 282 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 344 345 342 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 393 394 391 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 457 458 455 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 504 505 502 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 516 524 514 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0050239-t002">Tables 2</xref>
###xml 529 531 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050239-st002">S2</xref>
###xml 674 678 672 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 800 804 798 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 834 842 832 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050239-st002">Table S2</xref>
###xml 894 898 892 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 900 909 898 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050239-sg002">Figure S2</xref>
###xml 973 974 971 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 974 975 972 973 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1011 1020 1009 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050239-sg003">Figure S3</xref>
###xml 638 646 <span type="species:ncbi:9606">patients</span>
The association on haplotype testing and log-likelihood analysis was largely attributable to a nonsynonymous SNP in exon 12 of GLI1 (rs2228226C-->G; tSNP4). rs2228226 was associated with IBD (allelic frequency OR = 1.23, CI 1.07-1.40, p = 0.0026; homozygotes OR = 1.56, CI 1.15-2.11, p = 0.0047), CD (allelic frequency OR = 1.30, CI 1.08-1.55, p = 0.0053, homozygotes OR = 1.79, CI 1.21-2.65, p = 0.0048), and UC (allelic frequency OR = 1.19, CI 1.01-1.39, p = 0.04; homozygotes OR = 1.41, CI 0.98-2.03, p = 0.079) (Tables 2 and S2). These data suggest an allele specific dose response with a greater OR for homozygotes than heterozygote patients. Mutation screening of the GLI1 coding regions by direct sequencing failed to identify any novel SNPs. There was no association between seven additional GLI1 variants from dbSNP and IBD (Table S2). Despite tight linkage disequilibrium (LD) across GLI1 (Figure S2), there was notably less LD between rs2228226 and other tSNPs (r2 = 0.7) in both cases and controls (Figure S3), and this finding is likely to provide the explanation for the lack of association in neighbouring SNPs.
###end p 60
###begin p 61
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
Minor Allelic Frequencies for GLI1 Nonsynonymous SNP rs2228226 (tSNP4) in Scottish, English, and Swedish HC, IBD, CD, and UC
###end p 61
###begin title 62
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 55 56 55 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 123 124 123 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Meta-Analysis of Nonsynonymous GLI1 SNP rs2228226 (tSNP4) in Scotland, Cambridge, and Sweden Using Mantel-Haenszel Method (n = 5,352 Individuals)
###end title 62
###begin p 63
(A) IBD versus HCs.
###end p 63
###begin p 64
###xml 118 119 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 377 378 377 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
(B) UC versus HCs. There was no evidence of heterogeneity in the contribution of rs2228226 between the three cohorts (p = 0.825). 95% CIs for individual populations are represented by horizontal lines and population sizes by square boxes. The diamond represents the pooled OR (fixed effect model) with 95% CIs delineated by the diamond's width. Note the different range of the x-axis for (A) and (B).
###end p 64
###begin title 65
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
Replication of GLI1 Association in Two Independent Northern European IBD Cohorts and Meta-Analysis
###end title 65
###begin p 66
###xml 111 112 111 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 169 173 169 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 224 225 224 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 243 244 243 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 314 315 314 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 356 357 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 399 406 399 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0050239-t002">Table 2</xref>
###xml 460 463 460 463 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8722;3</sub>
###xml 665 666 665 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b003">3</xref>
###xml 700 701 700 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 801 808 801 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0050239-t002">Table 2</xref>
We then sought to replicate these findings in other populations. In a large IBD panel from Cambridge, England (n = 928 UC, 737 CD, 83 IBDU, and 589 HC) association with GLI1 was replicated by log-likelihood analysis in IBD (p = 0.009) and UC (p < 0.0001). rs2228226 was associated with IBD (OR 1.17, CI 1.00-1.36, p = 0.042) and UC (OR 1.21, CI 1.03-1.42, p = 0.017), but not CD in this population (Table 2). As in Scotland, there was no association with tSNPs1-3. Minor allelic frequencies differed slightly from the Scottish population; this difference is in keeping with that noted for a number of SNPs analysed for population stratification in the WTCCC study [3]. In the smaller Swedish cohort (n = 770), there was a consistent trend to association of rs2228226 with IBD (OR 1.14, CI 0.90-1.45) (Table 2) although this association was not statistically significant. However, the allelic frequencies in cases and controls were very similar in Scotland and Sweden indicating that the lack of statistical significance in the latter cohort is due to insufficient statistical power. There were no consistent genotype-phenotype associations across the populations, including stratification for colonic IBD.
###end p 66
###begin p 67
###xml 175 176 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 188 196 188 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g001">Figure 1</xref>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b031">31</xref>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b032">32</xref>
###xml 456 457 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 469 477 469 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g001">Figure 1</xref>
A meta-analysis of Scottish, English, and Swedish data for rs2228226, using the Mantel-Haenszel method with a fixed effects model on IBD versus HCs (OR 1.194, CI 1.089-1.309, p = 0.0002) (Figure 1A) confirmed the association of this variant in Northern Europe, achieving criteria for significance in a gene-centric study [31,32]. The meta-analysis was repeated separately for UC cases versus HCs with a similar effect size noted (OR 1.196, CI 1.077-1.327, p = 0.0008) (Figure 1B).
###end p 67
###begin p 68
###xml 209 213 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b033">33</xref>
Recognising the current problem with the publication of false positive findings in genetic association studies we estimated the probability that the association with disease risk found in the meta-analysis of GLI1 SNP rs2228226 represents a true (rather than false positive) association by adopting the FPRP approach described by Wacholder [33]. This gives an estimated probability that these findings represent a true finding of at least 92% (FPRP < 0.08). This method is designed to avoid over-interpretation of statistically significant findings that are not likely to signify a true positive. In our study, this parameter gives clear support to our interpretation of these data.
###end p 68
###begin title 69
The GLI1 Variant Encoded by rs2228226 Is Functionally Deficient in Activating GLI-Responsive Transcription In Vitro
###end title 69
###begin p 70
###xml 52 56 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 255 263 253 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g002">Figure 2</xref>
###xml 267 269 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b034">34</xref>
###xml 340 348 338 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g002">Figure 2</xref>
###xml 694 702 692 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g002">Figure 2</xref>
###xml 708 709 706 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g002">2</xref>
###xml 995 997 993 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b035">35</xref>
###xml 1126 1128 1120 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b036">36</xref>
###xml 1299 1307 1293 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g002">Figure 2</xref>
rs2228226C-->G is a missense mutation in exon 12 of GLI1, encoding a change from glutamine to glutamic acid (Q1100E). The mutation falls within a well conserved motif at the C terminus of mammalian GLI1 proteins, near a recognized transactivation domain (Figure 2A) [34]. The Q1100 residue is itself 100% conserved in all mammals examined (Figure 2B). In order to evaluate the functional consequences of the Q1100E mutation, we transfected either GLI1 Q1100 or the variant GLI1 E1100 into 293T cells. No significant differences in level of expression or cellular localization were detected between these GLI1 variants; both proteins were readily detectable in the nucleus of transfected cells (Figure 2C and 2D). Blinded quantitation of cellular localization demonstrated a range of cytoplasmic and nuclear localization that was similar for both GLI1 variants (unpublished data). We further evaluated the ability of each variant to activate the well-characterized GLI reporter 8xGli-Luciferase [35]. We utilized Gli2DeltaN, a very strong activator of 8xGli-Luciferase, as a positive control for GLI1 transcriptional activity [36]. While both GLI1 variants activated 8xGli-Luciferase above baseline, WT GLI1 Q1100 was 2-fold more efficient as a transcriptional activator than the variant GLI1 E1100 (Figure 2E).
###end p 70
###begin title 71
Q1100E Disrupts a Conserved Region of the GLI1 Protein and Reduces GLI1 Transcriptional Activity
###end title 71
###begin p 72
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b034">34</xref>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b057">57</xref>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b058">58</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b049">49</xref>
(A) Conservation of known functional domains in the Gli1 protein. Previously described Sufu binding, DNA binding, and transactivation domains [34,57,58] are shown schematically. Amino acid conservation of each domain is represented numerically and by shading of the bar below the domain. Red boxes indicate regions known to regulate GLI1 protein stability [49]. The conserved C-terminal domain that includes Q1100E is adjacent to a known transactivation domain.
###end p 72
###begin p 73
(B) Alignment of the C terminus of mammalian Gli1 proteins. This region (AA 1080-1106) is highly conserved in mammalian lineages.
###end p 73
###begin p 74
(C, D) GLI1 Q1100 and E1100 have similar cellular localization in 293T cells.
###end p 74
###begin p 75
###xml 414 415 410 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 533 534 529 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 578 579 574 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
(E) GLI1 E1100 is deficient in driving activation of the 8xGli-Luciferase reporter compared to GLI1 Q1100. GLI2DeltaN is a strong activator of 8xGli-Luciferase and serves as a positive control for GLI1 activation. The m8xGli-Luciferase construct contains eight mutant Gli binding sites and serves as a negative control. Data are shown from six triplicate experiments done using two different plasmid preparations (n = 18). Bar heights indicate mean fold activation above baseline, and error bars indicate standard error of the mean. p-Values were calculated using the Student's t-test.
###end p 75
###begin title 76
HH Pathway Activity Is Dysregulated in Colonic Inflammation
###end title 76
###begin p 77
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b026">26</xref>
###xml 292 300 292 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g003">Figure 3</xref>
###xml 306 307 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g003">3</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b014">14</xref>
###xml 423 424 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 442 443 442 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 464 465 464 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 545 553 545 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g003">Figure 3</xref>
###xml 605 606 605 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 657 658 657 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 705 713 705 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g003">Figure 3</xref>
###xml 749 753 749 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 872 873 872 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 884 893 884 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050239-sg005">Figure S5</xref>
###xml 961 970 961 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g003">Figures 3</xref>
###xml 976 985 976 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050239-sg006">Figure S6</xref>
###xml 1103 1112 1103 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050239-sg007">Figure S7</xref>
###xml 216 222 <span type="species:ncbi:9606">humans</span>
Extended in silico analysis of microarray data demonstrates that mRNA transcripts of PTCH and hedgehog-interacting protein (HHIP), along with HH protein, are greater in the distal compared with the proximal colon in humans, mirroring the expression gradient of GLI1 previously reported [26] (Figure 3A and 3B). GLI1, PTCH, and HHIP are pathway response elements whose expression levels predict pathway activity [14]. GLI1 (p = 0.0003), PTCH (p = 0.002), and HHIP (p = 0.0003) were lower in inflamed UC compared with HC from equivalent location (Figure 3C). IHH was lower in UC regardless of inflammation (p = 0.02). GLI1 expression was lower in CD than HC (p = 0.004) irrespective of inflammatory status (Figure 3D), a noteworthy finding given that GLI1 variation was also associated with CD in Scotland. PTCH was lower in inflamed CD compared with noninflamed CD and HC (p = 0.007) (Figure S5). GLI1 and PTCH were both lower in non-IBD inflammation versus HC (Figures 3D and Figure S6). Treatment for IBD (5-amino salicylic acid, thiopurines, and corticosteroids) did not influence expression of GLI1 (Figure S7). These data demonstrate overall down-regulation of HH pathway activity, including GLI1, PTCH, and HHIP, in areas of colonic inflammation.
###end p 77
###begin title 78
###xml 54 59 <span type="species:ncbi:9606">Human</span>
Expression of HH Signalling Components in the Healthy Human Adult Colon (HC) and UC
###end title 78
###begin p 79
(A) PTCH, HHIP, and GLI1 mRNA levels increase along the length of the healthy adult colon, from ascending colon (AC) to descending colon (DC) and sigmoid colon (SC).
###end p 79
###begin p 80
(B) HH protein expression in terminally differentiated enterocytes at the luminal surface, is greater in the distal colon compared with the proximal (vertical and horizontal arrows represent these gradients).
###end p 80
###begin p 81
(C) Quantitative analysis of mRNA levels of IHH, PTCH, GLI1, and HHIP in UC compared with noninflamed HC (HC N-I). To account for the gradients identified along the length of the healthy colon (a-b), the data from SC only are shown. QPCR data is presented for IHH as this gene was not present on the Agilent microarray chip.
###end p 81
###begin p 82
###xml 509 518 509 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050239-sg004">Figure S4</xref>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b021">21</xref>
###xml 626 627 626 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 741 742 741 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
(D) GLI1 expression in CD versus HC (N-I) and non-IBD inflammation (HC I) versus HC. Disease specimens are subcategorised into noninflamed (N-I) and inflamed (I) tissues. There was no change in levels of desert HH (DHH), PTCH2, GLI2, GLI3, SUFU, or DISP1 in either UC or CD compared with HC, or in non-IBD inflammation (unpublished data). Analysis of SHH mRNA demonstrated a mild increase in expression levels related to inflammation that is consistent with the known expression of SHH in inflammatory cells (Figure S4) [21]. Individual data points are plotted with horizontal lines representing the medians for each dataset. p-Values presented are derived from Kruskal-Wallis test, comparing levels in AC, DC, and SC, and from Mann-Whitney U-tests (UC versus HC (N-I)).
###end p 82
###begin title 83
###xml 4 10 4 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
Gli1+/lacZ Animals Exhibit Mortality and Heightened Morbidity in Response to Intestinal Inflammation Induced by 3% DSS Treatment
###end title 83
###begin p 84
###xml 354 360 354 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 350 360 350 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b037">37</xref>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
In vitro analysis of the GLI1 1100E variant demonstrated a 50% deficiency in transactivation function compared to WT GLI1 and our genetic analysis demonstrated an allele-specific dosage response, suggesting that a moderate reduction in GLI1 function may predispose to intestinal inflammatory disease. To specifically test this hypothesis, we treated Gli1+/lacZ mice [37] and their WT littermates with 3% DSS to induce acute intestinal inflammation.
###end p 84
###begin p 85
###xml 4 10 4 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 233 241 233 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g004">Figure 4</xref>
###xml 273 274 273 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 366 372 366 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 362 372 362 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 535 543 535 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g004">Figure 4</xref>
###xml 549 550 549 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g004">4</xref>
###xml 623 629 623 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 619 629 619 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 751 757 751 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 747 757 747 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
Gli1+/lacZ animals were rapidly and severely affected by DSS treatment. After 6 d, four out of nine had died, and three of the survivors demonstrated severe morbidity, with significant rectal bleeding and almost complete immobility (Figure 4A). In contrast, no WT animals (n = 14) died, all were mobile and showed less morbidity on days 5 and 6 after treatment. Gli1+/lacZ animals developed bloody diarrhoea and significant weight loss by day 4, whereas WT animals did not develop clinical signs or measurable weight loss until day 6 (Figure 4B and 4C). The rapid onset of weight loss, clinical signs, and mortality in Gli1+/lacZ animals was potentially indicative of extensive colonic inflammation, leading us to directly assess the histology of Gli1+/lacZ and WT colons after DSS administration.
###end p 85
###begin title 86
###xml 4 10 4 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
Gli1+/lacZ Animals Show Mortality, Severe Clinical Symptoms, and Profound Weight Loss after DSS Treatment
###end title 86
###begin p 87
###xml 91 92 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 118 124 118 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 114 124 114 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
(A) Kaplan-Meier survival curve. WT animals are 100% viable over the 6-d treatment period (n = 14). Nearly 50% of Gli1+/lacZ animals (four out of nine) die in response to 3% DSS treatment for 6 d.
###end p 87
###begin p 88
###xml 8 14 8 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 4 14 4 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
(B) Gli1+/lacZ animals display markedly more severe symptoms than WT animals after 4 or 6 d of 3% DSS treatment. 1, diarrhoea; 2, bloody diarrhoea; 4, severe bleeding/death. Each dot represents an individual animal and the solid line shows the mean observation in each cohort.
###end p 88
###begin p 89
###xml 8 14 8 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 4 14 4 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 24 25 24 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 83 84 83 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 95 96 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 117 118 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
(C) Gli1+/lacZ animals (n = 9) lose weight more rapidly than their WT littermates (n = 10). *, p < 0.05 by Student's t-test.
###end p 89
###begin title 90
###xml 4 10 4 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
Gli1+/lacZ Animals Develop More Severe Colonic Pathology Than WT Littermates in Response to DSS Treatment
###end title 90
###begin p 91
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 21 27 21 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 158 166 158 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g005">Figure 5</xref>
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g005">5</xref>
###xml 291 299 291 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g005">Figure 5</xref>
###xml 398 404 398 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 394 404 394 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 411 419 411 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g005">Figure 5</xref>
###xml 494 502 494 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g005">Figure 5</xref>
###xml 504 505 504 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g005">5</xref>
###xml 542 548 542 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 538 548 538 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 589 597 589 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g005">Figure 5</xref>
###xml 601 603 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b029">29</xref>
###xml 700 704 700 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
Untreated WT and Gli1+/lacZ animals had intact colonic mucosa; no clinical or histological signs of inflammatory disease were present prior to DSS treatment (Figure 5A and 5B). After 4 d of DSS treatment, WT colons exhibited evidence of inflammatory change but with few destructive lesions (Figure 5C), while extensive inflammatory infiltration and destructive colonic ulcers were prominent in Gli1+/lacZ mice (Figure 5D). After 6 d, the number, size, and invasiveness of inflammatory lesions (Figure 5E-5G) were significantly greater in Gli1+/lacZ animals, and the overall colitis score (Figure 5H) [29] was significantly greater. Taken together, these results demonstrate that the loss of a single Gli1 allele leads to increased sensitivity to DSS treatment as reflected by severe intestinal inflammatory pathology and clinical signs.
###end p 91
###begin title 92
###xml 4 10 4 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
Gli1+/lacZ Animals Demonstrate More Severe Intestinal Inflammation than WT Littermates in Response to DSS Treatment
###end title 92
###begin p 93
###xml 18 24 18 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 14 24 14 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
(A, B) WT and Gli1+/lacZ animals demonstrate normal thickness and structure of colonic mucosa in the absence of DSS.
###end p 93
###begin p 94
###xml 16 17 16 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
(C) WT animals (n = 4) exhibit mild colonic inflammation but do not develop substantial epithelial or ulcerative inflammatory pathology within 4 d of DSS treatment.
###end p 94
###begin p 95
###xml 8 14 8 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 4 14 4 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 24 25 24 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
(D) Gli1+/lacZ animals (n = 4) develop significant inflammatory infiltration, epithelial damage, and ulceration within 4 d of DSS treatment.
###end p 95
###begin p 96
###xml 16 17 16 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
(E) WT animals (n = 14) demonstrate ulceration following DSS treatment.
###end p 96
###begin p 97
###xml 8 14 8 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 4 14 4 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 170 171 170 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
(F) Gli1+/lacZ animals develop profound intestinal inflammation in response to 3% DSS treatment, with severe epithelial damage in long stretches of their colonic mucosa (n = 9).
###end p 97
###begin p 98
###xml 185 191 185 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 181 191 181 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 201 202 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 307 308 307 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
(G) Blinded histological scoring of colonic damage after 6 d of DSS treatment. Standard lengths of tissue from the mid colon and distal descending colon were scored in each animal. Gli1+/lacZ animals (n = 6) have more overall inflammatory foci and more long foci (10+ crypt units affected) than WT animals (n = 6). Each dot represents the number of observed foci in an individual animal; the solid line shows the mean observation in each cohort. Red dots indicate the animals that were analyzed for cytokine expression.
###end p 98
###begin p 99
###xml 35 37 35 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b029">29</xref>
###xml 53 59 53 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 49 59 49 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 102 103 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 155 156 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
(H) Comprehensive colitis scoring [29] of WT and Gli1+/lacZ animals after 4 and 6 d of DSS treatment. p-Values for (G) and (H) calculated by the Student's t-test.
###end p 99
###begin title 100
Intestinal Myeloid Cells Respond Directly to HH Signals
###end title 100
###begin p 101
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b038">38</xref>
###xml 110 116 110 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 106 116 106 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 197 201 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 671 679 668 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g006">Figure 6</xref>
###xml 860 866 857 863 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 856 866 853 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 876 884 873 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g006">Figure 6</xref>
###xml 886 887 883 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g006">6</xref>
###xml 909 911 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b021">21</xref>
###xml 912 914 909 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b022">22</xref>
###xml 935 937 932 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b023">23</xref>
###xml 1289 1297 1286 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g006">Figure 6</xref>
###xml 1299 1300 1296 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g006">6</xref>
###xml 1431 1439 1428 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g006">Figure 6</xref>
###xml 1445 1446 1442 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g006">6</xref>
###xml 1536 1544 1533 1541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g006">Figure 6</xref>
###xml 62 68 <span type="species:ncbi:10090">murine</span>
We previously demonstrated that HH signalling is paracrine in murine intestine and colon [38]. Given that Gli1+/lacZ animals contain a copy of bacterial beta-galactosidase under the control of the Gli1 promoter, they represent an excellent model to confirm this observation and identify cell types that are Hh-responsive (i.e., LacZ positive) before and during inflammatory disease. These studies revealed that no autocrine Hh signalling was detectable in untreated adult colon or following inflammatory stress; colonic epithelial cells do not express Gli1 or respond to Hh signals during colonic homeostasis or in areas of either mild or severe epithelial perturbation (Figure 6 and unpublished data). We did, however, detect a large population of Hh-responsive cells within the inflammatory infiltrate of DSS-induced ulcers after 4 d of DSS treatment in Gli1+/lacZ animals (Figure 6D-6F). Both lymphocytes [21,22] and myeloid cells [23] have recently been shown to respond to Hh signals outside of the gastrointestinal tract. We therefore investigated whether these populations were responding in the adult colon. We detected CD3-positive T lymphocytes, CD11b-positive myeloid cells, and CD11c-positive dendritic cells responding to Hh signalling in resting colon without DSS treatment (Figure 6A-6C). After 4 d of DSS treatment, significant numbers of Hh-responsive myeloid and dendritic cells were seen in inflammatory ulcers (Figure 6E and 6F). We did not detect Hh response amongst the infiltrating T cells in DSS-induced ulcers (Figure 6D). Examination of CD19-postive B lymphocytes in resting colon and after both 4 and 6 d of 3% DSS treatment revealed no clear Hh response in this population (unpublished data). Taken together, these data suggest that myeloid cells, including dendritic cells, are direct targets of Hh signalling in the colon both during homeostasis and after inflammatory stress. This finding, in association with the findings above, implies that direct Hh signalling may play a role in innate immune function in the colon.
###end p 101
###begin title 102
Intestinal Myeloid Cells Respond Directly to Hh Signalling during Homeostasis and Inflammation
###end title 102
###begin p 103
(A-C) No DSS treatment.
###end p 103
###begin p 104
(D-F) 4 d of 3% DSS.
###end p 104
###begin p 105
(A, D) Few CD3+ T lymphocytes respond to Hh signalling during colonic homeostasis. Infiltrating T cells in DSS-induced ulcers do not express Gli1 or respond to Hh signalling.
###end p 105
###begin p 106
###xml 120 126 120 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 116 126 116 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
(B, E) Many but not all CD11b+ myeloid cells respond to Hh signalling and express LacZ. After 4 d of DSS, ulcers in Gli1+/lacZ animals are filled with myeloid cells, many of which respond to Hh signals.
###end p 106
###begin p 107
(C, F) CD11c+ dendritic cells respond directly to Hh signals during homeostasis and inflammation. Nuclear DAPI staining was performed but has been omitted to allow clear visualization of co-expression of nuclear LacZ and cell surface markers.
###end p 107
###begin title 108
###xml 4 10 4 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
Gli1+/lacZ Animals Have Dramatically Increased IL-23p19 and Pro-inflammatory Cytokine Expression after DSS Treatment
###end title 108
###begin p 109
###xml 33 39 33 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 29 39 29 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 153 161 153 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g007">Figure 7</xref>
###xml 271 277 271 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 267 277 267 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 409 415 409 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 405 415 405 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 475 481 475 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 471 481 471 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 604 612 604 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g007">Figure 7</xref>
###xml 710 718 710 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g007">Figure 7</xref>
###xml 762 763 762 763 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 817 823 813 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 813 823 809 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 833 841 829 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g007">Figure 7</xref>
###xml 847 848 843 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g007">7</xref>
###xml 928 934 921 927 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 924 934 917 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
Overall, unchallenged WT and Gli1+/lacZ animals have a similar cytokine and chemokine profile as determined by QPCR examination of whole colonic tissue (Figure 7A). There are, however, several molecules (Cxcl2, Cxcl5, Cxcl10, and Arg1) that are modestly increased in Gli1+/lacZ animals, and a small decrease in IL-6 expression; these changes may indicate a subtle difference in the inflammatory milieu of Gli1+/lacZ animals at baseline. More strikingly, after 6 d of DSS Gli1+/lacZ animals demonstrate robustly up-regulated expression of several pro-inflammatory cytokines and chemokines compared to WT (Figure 7B). When baseline expression values are compared to values after DSS challenge for each genotype (Figure 7C), robust expression and up-regulation of TH1 cytokines, including IFNgamma, is detectable in Gli1+/lacZ animals (Figure 7B and 7C). We did not detect a significant difference in TGFbeta and IL-10 between Gli1+/lacZ and WT animals, suggesting that down-regulation of anti-inflammatory cytokines was not the primary mechanism of increased inflammation in this model.
###end p 109
###begin title 110
###xml 25 31 25 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 21 31 21 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 39 43 <span type="species:ncbi:10090">Mice</span>
Cytokine Analysis of Gli1+/lacZ and WT Mice after DSS Treatments Demonstrates Robust Pro-inflammatory Cytokine Activation
###end title 110
###begin p 111
###xml 79 80 79 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 94 100 94 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 90 100 90 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 118 119 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 307 313 307 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 303 313 303 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 372 378 372 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 368 378 368 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 388 389 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 495 501 495 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 491 501 491 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
(A, B) Cytokine and chemokine expression normalized to GAPDH is plotted on the y-axis for Gli1+/lacZ mice, and on the x-axis for WT animals. Gene expression levels that are statistically different are shown with stars. The dotted diagonal trend line indicates identical expression levels between WT and Gli1+/lacZ mice. (A) Cytokine and chemokine expression in WT and Gli1+/lacZ animals (n = 3) without DSS treatment. Cytokine and chemokine expression is low and very similar between WT and Gli1+/lacZ animals.
###end p 111
###begin p 112
###xml 38 44 38 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 34 44 34 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 54 55 54 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 186 192 186 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 182 192 182 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
(B) Cytokine expression in WT and Gli1+/lacZ animals (n = 4) after 6 d of 3% DSS treatment. Many pro-inflammatory cytokines and chemokines are significantly more highly expressed in Gli1+/lacZ animals compared to WT. Note the difference in axes in panels (A) and (B).
###end p 112
###begin p 113
###xml 80 86 80 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 76 86 76 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 133 134 133 134 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 142 143 142 143 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 185 191 185 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 181 191 181 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 204 205 204 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 218 219 218 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 244 245 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
(C) Fold change of cytokine expression from baseline to inflamed for WT and Gli1+/lacZ animals. We detect dramatic up-regulation of Th17 and Th1 pathway cytokines and chemokines in Gli1+/lacZ animals. *, p < 0.05; **, p < 0.01 by the Student's t-test.
###end p 113
###begin p 114
###xml 62 68 62 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 58 68 58 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 134 135 134 135 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b039">39</xref>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b040">40</xref>
###xml 321 327 321 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 317 327 317 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 415 421 415 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 411 421 411 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 458 466 458 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g007">Figure 7</xref>
###xml 472 473 472 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g007">7</xref>
###xml 619 620 619 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b004">4</xref>
###xml 632 634 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b040">40</xref>
###xml 722 726 722 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 611 617 <span type="species:ncbi:9606">humans</span>
###xml 626 630 <span type="species:ncbi:10090">mice</span>
The most highly expressed cytokine after DSS treatment in Gli1+/lacZ animals was IL-23p19, a molecule that drives differentiation of TH17 lymphocytes, key mediators of inflammation in several systems, including IBD [39,40]. IL-12 and IL-17, cytokines closely associated with IL-23, were also robustly up-regulated in Gli1+/lacZ animals. In fact, this entire pathway was highly up-regulated from the baseline in Gli1+/lacZ animals compared to WT littermates (Figure 7B and 7C). These findings are particularly interesting since the IL-23 pathway has recently been strongly implicated in IBD pathogenesis both in humans [4] and mice [40]. Taken together, these cytokine data confirm that animals lacking one genomic copy of Gli1 develop significantly increased inflammatory disease compared to WT littermates in response to the same inflammatory challenge.
###end p 114
###begin title 115
Discussion
###end title 115
###begin p 116
###xml 357 361 357 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 575 579 575 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 326 332 <span type="species:ncbi:9606">humans</span>
###xml 546 550 <span type="species:ncbi:10090">mice</span>
The data presented here provide the first evidence, to our knowledge, that intact HH signalling is critical in the mammalian gut response to inflammatory challenge, and suggest that reduced GLI1 function is implicated in IBD pathogenesis. We confirm that the HH signalling pathway is down-regulated in colonic inflammation in humans. We identify a specific GLI1 variant that is highly associated with UC/IBD, and demonstrate that the variant protein is functionally deficient as a transcriptional activator in vitro. Finally, we demonstrate that mice with a 50% reduction in Gli1 exhibit a heightened intestinal inflammatory response to DSS with significant up-regulation of the IL-23 pathway. Not only do these findings have clear implications for the understanding of IBD pathogenesis and suggest potential for therapeutic intervention, they are the first clear description of a functional role for HH signalling and GLI1 in bowel inflammation.
###end p 116
###begin p 117
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b011">11</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b013">13</xref>
###xml 548 550 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b041">41</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b042">42</xref>
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b043">43</xref>
###xml 671 672 671 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 677 679 677 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 685 687 685 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b031">31</xref>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b032">32</xref>
###xml 805 807 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b011">11</xref>
###xml 808 810 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b013">13</xref>
###xml 811 813 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b044">44</xref>
###xml 814 816 814 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b045">45</xref>
###xml 987 989 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b046">46</xref>
###xml 553 557 <span type="species:ncbi:307630">colo</span>
The inherited variation in the GLI1 gene that we have detected is associated with IBD and UC, in both Scotland and England, with findings for rs2228226 confirmed by meta-analysis of over 5,000 individuals, with OR of 1.19. Evidence for an effect in CD is seen in the present study, but the predominant effect is clearly related to UC, consistent with the reported IBD2 linkage studies [11,13]. The magnitude of this association is entirely in line with the effect size noted in a number of recent studies of complex disease genetics, including CD [41], colo-rectal cancer [42], and coeliac disease [43]. The level of significance attained satisfies suggested criteria of p < 10-4 to 10-6 for gene-centric studies [31,32]. Population heterogeneity has been previously described at the IBD2 linkage region [11,13,44,45]. The three Northern European populations studied here have previously demonstrated similar contribution of other IBD susceptibility genes/loci, including NOD2 and IBD5 [46].
###end p 117
###begin p 118
###xml 495 496 495 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b008">8</xref>
###xml 497 498 497 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b009">9</xref>
###xml 640 644 640 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRGM</italic>
###xml 652 654 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b010">10</xref>
###xml 655 657 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b047">47</xref>
###xml 724 726 724 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b048">48</xref>
Whilst our resequencing efforts identify rs2228226 as the only coding variant associated with IBD, further deep resequencing will be important in the future as the haplotype analysis and log-likelihood analyses raise the possibility that other germ-line variants may also contribute to IBD risk. These need be explored formally-specifically the role of intronic variants, long-range promoter effects, and/or copy number variation. In this context, several complex disease genes, including NOD2 [8,9], have multiple independent mutations conferring disease risk, some disease genes have no causative mutations within coding sequences (e.g., IRGM in CD [10,47]), and synonymous SNPs may be associated with functional effects [48].
###end p 118
###begin p 119
###xml 526 528 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b049">49</xref>
###xml 556 562 <span type="species:ncbi:10090">murine</span>
rs2228226C-->G encodes a change from glutamine to glutamic acid (Q1100E). Our in vitro data demonstrate that GLI1 1100E is a subfunctional transcriptional activator compared to WT GLI1, though it is appropriately synthesized and localized. The Q1100E mutation causes a significant charge change in a conserved region directly adjacent to the known transactivation region of GLI1; this change could directly modify transactivation activity, disrupt the structure of the transactivation domain, or affect protein stabilization [49], decreasing activity. Our murine data confirm that reduction in GLI1 activity has significant consequences for the inflammatory response.
###end p 119
###begin p 120
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b038">38</xref>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b050">50</xref>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b051">51</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b038">38</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b051">51</xref>
###xml 823 825 823 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b015">15</xref>
###xml 826 828 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b019">19</xref>
###xml 964 966 964 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b052">52</xref>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 37 43 <span type="species:ncbi:9606">humans</span>
###xml 400 405 <span type="species:ncbi:9606">human</span>
###xml 509 515 <span type="species:ncbi:9606">humans</span>
Intestinal HH signalling in mice and humans is exclusively paracrine: HH ligands in the epithelium signal to the HH response network (PTCH, GLI1, HHIP) in the mesenchyme [38,50,51]. This has been demonstrated during development [38], homeostasis (Kolterud A, Grosse AS, Zacharias WJ, Walton KD, and Gumucio DL, personal correspondence), malignancy [51], and now, in this report, in inflammation. The human expression data presented here also support the relevance of the HH pathway to colonic inflammation in humans. GLI1 expression, a reliable indicator of pathway activity, is down-regulated in all forms of colonic inflammation examined (UC, CD, and non-IBD inflammation). Whilst embryonic HH pathway activity is reportedly recapitulated in diverse organs/tissues in response to acute injury and inflammatory challenge [15-19], GLI1 expression is notably decreased in psoriasis, a disease of the epithelial border that shares some pathogenic features with IBD [52].
###end p 120
###begin p 121
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b053">53</xref>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b054">54</xref>
###xml 554 560 554 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 550 560 550 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 363 369 <span type="species:ncbi:9606">humans</span>
###xml 561 566 <span type="species:ncbi:10090">mouse</span>
###xml 707 712 <span type="species:ncbi:9606">human</span>
The localisation of HH protein demonstrated here is similar to that shown for IHH by van den Brink and colleagues by in situ hybridisation [53]. However, along with other commentators, we would urge caution in the use of the commercially available HH pathway antibodies presently available [54]. We note further that the expression analysis of disease samples in humans is inherently limited in that it only depicts a complex process at a late time point in established disease. Nonetheless, in combination with studies utilizing models (such as the Gli1+/lacZ mouse) to directly correlate HH response with inflammatory challenge, these studies provide useful information to help elucidate the aetiology of human inflammatory disease.
###end p 121
###begin p 122
###xml 4 10 4 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b037">37</xref>
###xml 660 666 660 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 656 666 656 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
###xml 1014 1016 1014 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b015">15</xref>
###xml 1509 1514 <span type="species:ncbi:9606">human</span>
###xml 1515 1521 <span type="species:ncbi:10090">murine</span>
Gli1+/lacZ animals, which have only 50% of the WT level of Gli1, develop severe and rapid inflammation in response to DSS, despite having normal histological structure and a largely WT cytokine and chemokine profile prior to DSS treatment. These data, to our knowledge, provide the first description of a phenotype for reduced Gli1 function [37], and demonstrate the key role that a full complement of Gli1 plays in protection from inflammatory disease. Our in vitro data demonstrate that GLI1 E1100 is capable of activating some GLI1 response, suggesting that under homeostatic conditions, GLI1 E1100 could perform adequately. Similar to the situation in Gli1+/lacZ animals, however, under conditions of inflammatory stress, GLI1 E1100 can only function at 50% of the level of WT GLI1. Whether the predisposition to inflammation in these systems is a direct result of lowered HH signal transduction within HH-responsive inflammatory cells or reflects the effect of lower HH signals on other stromal target cells [15] that, in turn, release signals that impact the integrity of the epithelial layer or the inflammatory phenotype of resident immune cells is not yet clear, and will be an important area of future study. Furthermore, we believe that it will be important to determine if other primary (e.g., germ-line variation in other HH pathway genes and the HH interactome, epigenetic changes, and gene-environmental interactions) or secondary phenomena (e.g., due to alterations in commensal flora) in the human/murine intestine alter the transduction of HH signals in response to acute and chronic inflammatory challenge.
###end p 122
###begin p 123
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b023">23</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b055">55</xref>
###xml 504 510 504 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/lacZ</sup>
###xml 500 510 500 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1<sup>+/lacZ</sup></italic>
We have additionally shown that the HH pathway may directly modify the innate immune response through signalling to myeloid target cells. This finding is in accord with recent data demonstrating a crucial role for Hh signalling in myeloid cell maturation in the spleen [23]. Interestingly, myeloid cell populations are known to modify the intestinal inflammatory milieu through a significant impact on the IL-23/IL-17 pathway [55], a pathway that we find to be clearly and distinctly dysregulated in Gli1+/lacZ inflammation. Taken together, these data raise the exciting possibility that the normal role of HH signalling is to promote a tolerogenic phenotype in mucosal myeloid cells. In the face of reduced HH signal transduction in these cells, minor inflammatory stimuli may trigger robust inflammatory responses. Future studies directly investigating this hypothesis by specifically testing the effects of Hh signalling on intestinal myeloid cells will be crucial to the evolution of a more complete understanding the role of Hh in intestinal inflammation.
###end p 123
###begin title 124
Limitations of the Study
###end title 124
###begin p 125
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 502 506 502 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 506 509 506 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 706 707 706 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 713 717 713 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 760 763 760 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rag</italic>
###xml 778 782 778 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rag1</italic>
###xml 782 785 782 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 334 338 <span type="species:ncbi:10090">mice</span>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
###xml 787 791 <span type="species:ncbi:10090">mice</span>
A number of issues meriting further work emerge from the present study. Firstly, deep resequencing of the entire GLI1 gene is required to identify additional variants that contribute to the overall disease association noted for the gene. Secondly, the in vivo examination of reduced Gli1 function is presently limited to heterozygous mice. Despite the robust phenotype observed in these mice following acute inflammatory challenge, these findings need to be extended to homozygous null mutant animals (Gli1-/-). Thirdly, additional animal models of colitis, particularly of chronic disease, need to be examined; for example, trinitrobenzene sulfonic acid (TNBS) induced colitis, or adoptive transfer of CD4+CD45RBhigh T cells into recombinase-activating gene (rag)-1 deficient (rag1-/-) mice. Finally, we have not yet directly examined the phenotype of reduced GLI1 function in antigen presenting cells in vitro.
###end p 125
###begin title 126
Conclusions
###end title 126
###begin p 127
###xml 467 471 467 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOD2</italic>
###xml 476 482 476 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-23R</italic>
###xml 592 599 592 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATG16L1</italic>
###xml 604 608 604 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRGM</italic>
###xml 790 795 <span type="species:ncbi:9606">human</span>
###xml 842 847 <span type="species:ncbi:10090">mouse</span>
A key paradigm emerging in complex disease genetics is that gene discovery may lead to fundamental shifts in the direction of basic and translational research efforts. Recently, it is apparent that mechanistic insights may have greater significance than the index gene discovery itself, especially when one considers the small contribution each locus/variant makes towards disease susceptibility. IBD has provided several recent examples. Notably, the discoveries of NOD2 and IL-23R have launched academic and pharmaceutical research efforts into innate immunity and Th17 signalling, whereas ATG16L1 and IRGM have focused much attention on the role of autophagy in CD pathogenesis. In the present study, our genetic studies led in turn to detailed observations of expression in established human disease as well as a mechanistic study in the mouse. We believe that these combined findings have the potential to open entirely novel lines of enquiry that may have great consequences for the understanding of IBD pathogenesis and potentially for inflammatory pathways in other HH-expressing organs (e.g., skin, lung, bone).
###end p 127
###begin p 128
###xml 237 241 237 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 367 371 367 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1</italic>
###xml 1131 1133 1131 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b056">56</xref>
###xml 511 516 <span type="species:ncbi:10090">mouse</span>
In conclusion, we demonstrate here the dysregulation of a developmental signalling pathway in IBD for the first time to our knowledge. Furthermore, we show that these effects are in part genetically determined, with evidence implicating GLI1 as an IBD2 gene, and identification of a specific variant with reduced transcriptional activity. The functional relevance of Gli1 is demonstrated by the severe intestinal inflammation that develops in the face of a 50% reduction in Gli1 concentration in an established mouse model of colitis. Taken together, these data strongly argue that tolerance to inflammatory stimuli requires a fully functional HH signal transduction network. With HH signalling modulators under active investigation in a number of clinical trials ( and ), these data provide promise for the development of novel therapeutic strategies. Since the use of HH inhibitors has recently been advocated for the treatment of certain tumours that secrete HH, our finding that reduced HH signalling has inflammatory consequences suggests that inflammatory status should be carefully followed during upcoming Phase II trials [56].
###end p 128
###begin title 129
Supporting Information
###end title 129
###begin title 130
Schematic of Activation Events in the HH Signalling Pathway
###end title 130
###begin p 131
###xml 40 50 40 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 56 58 56 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hh</italic>
###xml 890 892 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b014">14</xref>
###xml 893 895 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b054">54</xref>
###xml 40 50 <span type="species:ncbi:7227">Drosophila</span>
There are three mammalian homologues of Drosophila gene Hh, of which SHH and IHH have important functions in the gut and the immune system. Intestinal HH expression is limited to epithelial cells, while HH-response genes are expressed only in intestinal mesenchyme. In epithelial cells, soluble HH is processed in the Golgi and released via Dispatched (DISP1). In the mesenchyme, upon HH binding to the transmembrane receptor PTCH, PTCH can no longer repress SMO, and SMO prevents cleavage of transcription factors GLI2 and GLI3 from activator to repressor form; GLI activator forms then predominate, and transcription is activated in a raft of downstream targets. Direct early targets of HH signals include GLI1, a strong transcriptional activator which acts an amplifier of HH signalling, PTCH, and HHIP, a feedback inhibitor; these markers can be used as indicators of pathway activity [14,54].
###end p 131
###begin p 132
(66 KB PPT)
###end p 132
###begin p 133
Click here for additional data file.
###end p 133
###begin title 134
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
The Haplotype Structure in GLI1 and Surrounding Haplotype Blocks Are Presented in Haploview from Genotyping in UC (A) and CD (B)
###end title 134
###begin p 135
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
There is a haplotype block spanning the GLI1 gene that does not extend into neighbouring genes. LD is described here by D' values.
###end p 135
###begin p 136
(1 MB TIF)
###end p 136
###begin p 137
Click here for additional data file.
###end p 137
###begin title 138
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
###xml 133 134 133 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 134 135 134 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The Haplotype Structure of the Four GLI1 tSNPs from the Scottish HCs and UC Population and from HapMap CEU Data Is Demonstrated with r2 Values
###end title 138
###begin p 139
###xml 71 80 71 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050239-sg002">Figure S2</xref>
###xml 87 88 87 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 88 89 88 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 119 120 119 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 141 142 141 142 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
The LD between rs2228226 and neighbouring SNPs is overestimated by D' (Figure S2). The r2 value between rs2228226 (tSNP4) and rs2228224 (tSNP3) in UC is 0.7, providing an explanation for the evidence of association at rs2228226 in the absence of association at neighbouring SNPs.
###end p 139
###begin p 140
(325 KB TIF)
###end p 140
###begin p 141
Click here for additional data file.
###end p 141
###begin title 142
Quantitative Analysis of mRNA Levels by Microarray and RT-PCR of SHH in UC Compared with Noninflamed HCs
###end title 142
###begin p 143
###xml 205 213 205 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050239-g003">Figure 3</xref>
###xml 565 566 565 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
For the microarray data on the left, disease specimens are taken from the ascending colon (AC), descending colon (DC), and sigmoid colon (SC). To take into account anatomical gradients of HH signalling in Figure 3, RT-PCR (right) is performed on samples from SC only, and UC samples are subcategorised into noninflamed (N-I) and inflamed (I). This observation validates the microarray data and shows that the modest increase in SHH is present only with inflammation. This result is of interest given the fact that inflammatory cells have been shown to express SHH. p-Values represent Kruskal-Wallis analysis of HC versus UC for each anatomical location.
###end p 143
###begin p 144
(1.9 MB TIF)
###end p 144
###begin p 145
Click here for additional data file.
###end p 145
###begin title 146
Quantitative Analysis of mRNA Levels by Microarray and RT-PCR of SHH, GLI1, PTCH, and HHIP in CD Compared with Noninflamed HCs
###end title 146
###begin p 147
###xml 176 177 176 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Disease specimens are taken from the terminal ileum (TI), ascending colon (AC), and sigmoid colon (SC), and are subcategorised into noninflamed (N-I) and inflamed (I) tissues. p-Values represent Kruskal-Wallis analysis of HC, CD (N-I), and CD (I) for each anatomical location.
###end p 147
###begin p 148
(1.8 MB JPG)
###end p 148
###begin p 149
Click here for additional data file.
###end p 149
###begin title 150
###xml 122 130 <span type="species:ncbi:9606">patients</span>
Analysis of SHH, PTCH, and HHIP mRNA Levels by Microarray in Colonoscopic Biopsies from the Sigmoid Colon (SC) of Non-IBD patients with Inflammation (I) Compared with Noninflamed HCs (NI)
###end title 150
###begin p 151
(1.7 MB JPG)
###end p 151
###begin p 152
Click here for additional data file.
###end p 152
###begin title 153
Analysis of GLI1 Expression in UC by Treatment
###end title 153
###begin p 154
###xml 390 391 390 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 26 34 <span type="species:ncbi:9606">patients</span>
Data are presented for UC patients on no treatment (Rx), on a 5-amino salicylic acid (5-ASA) only, on azathioprine (AZA), or mercaptopurine (MP) with or without a 5-ASA and on steroids (oral and topical) with or without a 5-ASA. Individual data points are represented with horizontal lines representing medians. There was no difference between any of the groups on analysis by Mann-Whitney U-testing.
###end p 154
###begin p 155
(932 KB JPG)
###end p 155
###begin p 156
Click here for additional data file.
###end p 156
###begin title 157
The Specificity of the N-19 HH Antibody Is Demonstrated with Application of the Primary Antibody, Primary Antibody + SHH Blocking Peptide Pre-absorbed Overnight, and with Primary Antibody Omitted
###end title 157
###begin p 158
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050239-b054">54</xref>
This figure demonstrates that the N-19 HH antibody reacts with the peptide but does not preclude it from cross-reacting with other proteins. Indeed, we would agree with other commentators [54] in urging caution in the use of this and other presently available HH antibodies for immunohistochemistry.
###end p 158
###begin p 159
(289 KB TIF)
###end p 159
###begin p 160
Click here for additional data file.
###end p 160
###begin title 161
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
GLI1 Haplotype Frequencies in IBD, UC, CD, and HC in (A) Scotland, (B) Cambridge, England, and (C) Sweden
###end title 161
###begin p 162
###xml 4 5 4 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 22 23 22 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 58 59 58 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 152 153 150 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 175 176 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 294 295 292 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
tSNP1, rs3817474; tSNP2, rs2228225; tSNP3, rs2228224; tSNP4, rs2228226. Differences between IBD, CD, UC, and HC frequencies are shown, calculated by chi2 test, with two-sided p-value, OR, and 95% CIs. Estimated haplotype frequencies were calculated using Haploview, version 3.2. Log-likelihood p-values (calculated on the PM/EH platform with 10,000 permutations and 15 degrees of freedom) are given for each analysis.
###end p 162
###begin p 163
(61 KB DOC)
###end p 163
###begin p 164
Click here for additional data file.
###end p 164
###begin title 165
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLI1</italic>
Details of the 11 GLI1 SNPs Genotyped in the Scottish Population, Including the Four tSNPs Used for Haplotype Analysis
###end title 165
###begin p 166
###xml 3 4 1 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 123 124 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 153 154 151 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
chi2 analysis for allelic frequency and homozygosity of each tSNP for UC and CD versus HCs is presented with corresponding p-values, OR, and 95% CIs. *, n = 370 for SNPs 1-4 and 7-9; U/K, unknown.
###end p 166
###begin p 167
(90 KB DOC)
###end p 167
###begin p 168
Click here for additional data file.
###end p 168
###begin title 169
Supplementary Methods
###end title 169
###begin p 170
(43 KB DOC)
###end p 170
###begin p 171
Click here for additional data file.
###end p 171
###begin p 172
###xml 639 645 639 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/LacZ</sup>
###xml 13 21 <span type="species:ncbi:9606">patients</span>
###xml 174 182 <span type="species:ncbi:9606">patients</span>
###xml 324 329 <span type="species:ncbi:9606">Human</span>
We thank all patients and controls who participated in this study; Linda Smith, Janice Fennell, and Sue Aitken (Western General Hospital [WGH], Edinburgh) for recruitment of patients and controls; Angie Fawkes (Wellcome Trust Clinical Research Facility Genetics Core, WGH site, Edinburgh) for running Taqman assays; the MRC Human Genetics Unit for running sequencing; Andrzej Dlugosz (Department of Dermatology, University of Michigan) for reagents and assistance with the functional analysis of GLI1 variants and Dr. Alexandra Joyner (Developmental Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY) for providing Gli1+/LacZ animals.
###end p 172
###begin title 173
Abbreviations
###end title 173
###begin p 174
Crohn's disease
###end p 174
###begin p 175
confidence interval
###end p 175
###begin p 176
dextran sodium sulphate
###end p 176
###begin p 177
false positive report probability
###end p 177
###begin p 178
###xml 38 43 <span type="species:ncbi:9606">human</span>
glioma-associated oncogene homolog 1 (human)
###end p 178
###begin p 179
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
glioma-associated oncogene homolog 1 (mouse): HC, healthy controls
###end p 179
###begin p 180
###xml 10 15 <span type="species:ncbi:9606">human</span>
hedgehog (human)
###end p 180
###begin p 181
###xml 10 15 <span type="species:ncbi:10090">mouse</span>
hedgehog (mouse)
###end p 181
###begin p 182
hedgehog-interacting protein
###end p 182
###begin p 183
Hardy-Weinberg equilibrium
###end p 183
###begin p 184
inflammatory bowel disease
###end p 184
###begin p 185
colonic IBD type unclassified
###end p 185
###begin p 186
Indian Hedgehog
###end p 186
###begin p 187
linkage disequilibrium
###end p 187
###begin p 188
odds ratio
###end p 188
###begin p 189
patched
###end p 189
###begin p 190
quantitative reverse-transcription PCR
###end p 190
###begin p 191
Sonic Hedgehog
###end p 191
###begin p 192
smoothened
###end p 192
###begin p 193
tagging single nucleotide polymorphism
###end p 193
###begin p 194
ulcerative colitis
###end p 194
###begin p 195
wild type
###end p 195
###begin title 196
References
###end title 196
###begin article-title 197
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
###end article-title 197
###begin article-title 198
Unravelling the pathogenesis of inflammatory bowel disease
###end article-title 198
###begin article-title 199
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
###end article-title 199
###begin article-title 200
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene
###end article-title 200
###begin article-title 201
Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease
###end article-title 201
###begin article-title 202
Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis
###end article-title 202
###begin article-title 203
A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1
###end article-title 203
###begin article-title 204
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
###end article-title 204
###begin article-title 205
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
###end article-title 205
###begin article-title 206
Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility
###end article-title 206
###begin article-title 207
Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12
###end article-title 207
###begin article-title 208
Phenotype-stratified genetic linkage study demonstrates that IBD2 is an extensive ulcerative colitis locus
###end article-title 208
###begin article-title 209
The IBD2 locus shows linkage heterogeneity between ulcerative colitis and Crohn disease
###end article-title 209
###begin article-title 210
The hedgehog signalling pathway in the gastrointestinal tract: implications for development, homeostasis, and disease
###end article-title 210
###begin article-title 211
Postnatal recapitulation of embryonic hedgehog pathway in response to skeletal muscle ischemia
###end article-title 211
###begin article-title 212
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 103 109 <span type="species:ncbi:9606">humans</span>
Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans
###end article-title 212
###begin article-title 213
###xml 78 82 <span type="species:ncbi:10116">rats</span>
The hedgehog pathway regulates remodeling responses to biliary obstruction in rats
###end article-title 213
###begin article-title 214
Expression of the developmental Sonic hedgehog (Shh) signalling pathway is up-regulated in chronic lung fibrosis and the Shh receptor patched 1 is present in circulating T lymphocytes
###end article-title 214
###begin article-title 215
Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer
###end article-title 215
###begin article-title 216
Hedgehog signaling controls thymocyte progenitor homeostasis and differentiation in the thymus
###end article-title 216
###begin article-title 217
Sonic hedgehog promotes cell cycle progression in activated peripheral CD4(+) T lymphocytes
###end article-title 217
###begin article-title 218
###xml 76 81 <span type="species:ncbi:9606">human</span>
Sonic hedgehog signaling modulates activation of and cytokine production by human peripheral CD4+ T cells
###end article-title 218
###begin article-title 219
###xml 25 30 <span type="species:ncbi:9606">human</span>
Survival and function of human thymic dendritic cells are dependent on autocrine Hedgehog signaling
###end article-title 219
###begin article-title 220
Characterization of sonic hedgehog as a novel NF-{kappa}B target gene that promotes NF-{kappa}B-mediated apoptosis resistance and tumor growth in vivo
###end article-title 220
###begin article-title 221
###xml 25 30 <span type="species:ncbi:9606">human</span>
Hh pathway expression in human gut tissues and in inflammatory gut diseases
###end article-title 221
###begin article-title 222
Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis
###end article-title 222
###begin article-title 223
Classification of inflammatory bowel disease
###end article-title 223
###begin article-title 224
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
###end article-title 224
###begin article-title 225
Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines
###end article-title 225
###begin article-title 226
Model-free analysis and permutation tests for allelic associations
###end article-title 226
###begin article-title 227
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants
###end article-title 227
###begin article-title 228
Betting odds and genetic associations
###end article-title 228
###begin article-title 229
Assessing the probability that a positive report is false: an approach for molecular epidemiology studies
###end article-title 229
###begin article-title 230
GLI activates transcription through a herpes simplex viral protein 16-like activation domain
###end article-title 230
###begin article-title 231
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
Expression of the mouse Fgf15 gene is directly initiated by Sonic hedgehog signaling in the diencephalon and midbrain
###end article-title 231
###begin article-title 232
###xml 119 124 <span type="species:ncbi:9606">human</span>
A previously unidentified amino-terminal domain regulates transcriptional activity of wild-type and disease-associated human GLI2
###end article-title 232
###begin article-title 233
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation
###end article-title 233
###begin article-title 234
Epithelial hedgehog signals pattern the intestinal crypt-villus axis
###end article-title 234
###begin article-title 235
Interleukin-23 drives innate and T cell-mediated intestinal inflammation
###end article-title 235
###begin article-title 236
IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6
###end article-title 236
###begin article-title 237
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
###end article-title 237
###begin article-title 238
Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21
###end article-title 238
###begin article-title 239
Newly identified genetic risk variants for celiac disease related to the immune response
###end article-title 239
###begin article-title 240
Exclusion of linkage of Crohn's disease to previously reported regions on chromosomes 12, 7, and 3 in the Belgian population indicates genetic heterogeneity
###end article-title 240
###begin article-title 241
Genome wide scan in a Flemish inflammatory bowel disease population: support for the IBD4 locus, population heterogeneity, and epistasis
###end article-title 241
###begin article-title 242
New genes in inflammatory bowel disease: lessons for complex diseases
###end article-title 242
###begin article-title 243
Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease
###end article-title 243
###begin article-title 244
A "silent" polymorphism in the MDR1 gene changes substrate specificity
###end article-title 244
###begin article-title 245
Dual degradation signals control Gli protein stability and tumor formation
###end article-title 245
###begin article-title 246
Depletion of the colonic epithelial precursor cell compartment upon conditional activation of the hedgehog pathway [Abstract]
###end article-title 246
###begin article-title 247
A paracrine requirement for hedgehog signalling in cancer
###end article-title 247
###begin article-title 248
Lack of evidence for activation of the hedgehog pathway in psoriasis
###end article-title 248
###begin article-title 249
Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation
###end article-title 249
###begin article-title 250
Hedgehog signaling in development and homeostasis of the gastrointestinal tract
###end article-title 250
###begin article-title 251
Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses
###end article-title 251
###begin article-title 252
Hedgehog, paneth cells, and colon cancer: a cautionary note for the use of systemic agonists/antagonists
###end article-title 252
###begin article-title 253
The GLI gene is a member of the Kruppel family of zinc finger proteins
###end article-title 253
###begin article-title 254
Mammalian suppressor-of-fused modulates nuclear-cytoplasmic shuttling of Gli-1
###end article-title 254
###begin p 255
paragraph sign These authors are joint senior authors on this work.
###end p 255
###begin p 256
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
###xml 314 322 <span type="species:ncbi:9606">patients</span>
Author contributions. CWL, WJZ, CLN, ERN, LD, DLG, and JS designed the experiments/the study. CWL, WJZ, MT, CLN, JC, LT, JK, HED, IDRA, HDA, LD, MP, and SEMH collected data or did experiments for the study. CWL, WJZ, MT, AT, JK, LD, and DLG analyzed the data. CWL, MT, CLN, LT, G-TH, IRDA, SF, MGD and MP enrolled patients. CWL and WJZ wrote the first draft of the paper. CWL, WJZ, MT, AT, HC, MGD, SEMH, DLG, and JS contributed to writing the paper.
###end p 256
###begin p 257
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding:</bold>
Funding: The work is funded by a Wellcome Trust Programme Grant (072789/Z/03/Z), MRC (G0000657-53203), Cancer Research (CR)-UK (G348/A3758), CORE, National Institutes of Health (NIH) (R01-DK065850), The University of Michigan's Training Program in Organogenesis (NIH T32-HD007505 to WZ), the Scottish Executive Chief Scientist (K/OPR/2/2/D333), and the British Medical Association (Joan Dawkins prize). None of the funding agencies had any input into the study design, data collection and analysis, the decision to publish, or in the preparation of this manuscript.
###end p 257
###begin p 258
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests:</bold>
Competing Interests: Lauri Diehl is a paid employee of Genentech, Inc and a stockholder in that company. While this paper does not describe any Genentech product, it is possible that these findings may be relevant to a pathway or pathways of interest to the company for current or future therapeutic agents. None of the other authors have any competing interests to declare.
###end p 258

